Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Working Capital/Sales

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 1.101.421.241.251.15

What is the latest Working Capital/Sales ratio of NATCO PHARMA ?

The latest Working Capital/Sales ratio of NATCO PHARMA is 1.10 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.10
Mar20241.42
Mar20231.24
Mar20221.25
Mar20211.15

How is Working Capital/Sales of NATCO PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 1.1
-22.54
Mar2024 1.42
14.52
Mar2023 1.24
-0.80
Mar2022 1.25
8.70
Mar2021 1.15 -

Other Financial Ratios of NATCO PHARMA


Compare Working Capital/Sales ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹19,480.7 Cr -3.3% 7% 41.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,937.0 Cr -1.4% -7.2% 0.5% Stock Analytics
DIVIS LABORATORIES ₹165,359.0 Cr 5.7% 0.3% 14.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,431.0 Cr 1.5% -6.5% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,114.0 Cr 0.7% -7.4% 9.9% Stock Analytics
CIPLA ₹100,028.0 Cr 0.5% -7.1% -14.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-3.3%

7%

41.5%

SENSEX

0.6%

1.5%

6.6%


You may also like the below Video Courses